Laboratory Test Nomenclature updated in Finland

On November 28, 2024, the updated version of the Finnish Laboratory Tests Nomenclature was published by the Finnish Institute for Health and Welfare (THL) to come into force on January 1, 2025. 

Laboratory Tests Nomenclature is intended to be a common classification between the physician responsible for the patient’s care and the unit performing laboratory tests used in healthcare services and information systems. The nomenclature harmonizes the practice of requesting and reporting laboratory tests and compiling statistics. The nationally uniform nomenclature also forms the basis for electronic data transfer and the utilization of patient data across organizational boundaries. The nomenclature covers laboratory studies in clinical chemistry, clinical physiology, clinical microbiology, clinical neurophysiology, genetics, and pathology. The Laboratory Tests Nomenclature is also used to code the tests in private settings with coverage from the national public payor (KELA). 

Six new codes were introduced in the updated version. Some examples of newly introduced codes are provided below:

• 3814 F-Hemoglobin, human (qualitative), screening;
• 6817 Li-Immunoglobulin, light chains, Kappa, free;
• 6819 Pt-Gynecological smear and papillomavirus, nucleic acid, high risk (qualitative).

The letter before the code name means the following: F – feces, Li – cerebrospinal fluid, Pt – patient.

See the full details in Finnish here and here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.